Have a personal or library account? Click to login
Alternative treatment of psoriasis - is rifampicin a mild immunosupressor? / Alternativna terapija psorijaze: da li rifampicin ima blago imunosupresivno dejstvo? Cover

Alternative treatment of psoriasis - is rifampicin a mild immunosupressor? / Alternativna terapija psorijaze: da li rifampicin ima blago imunosupresivno dejstvo?

Open Access
|Feb 2013

Abstract

Psoriasis is a common T-cell-mediated autoimmune inflammatory disease. Conventional systemic therapy includes: methotrexate, cyclosporine, retinoids and psoralen ultraviolet A, which are effective, but associated with toxicity and adverse effects which may limit their long-term use. Although effective as well, data on the long-term safety of newly introduced biologic agents are still not available. Herein, we present our clinical experience with rifampicin in the treatment of psoriasis, and review of literature regarding its potential mechanisms of action.

Language: English
Page range: 5 - 12
Published on: Feb 12, 2013
Published by: Serbian Association of Dermatovenereologists (SAD)
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2013 Ivan Grozev, Jana Kazandjeva, Nikolai Tsankov, published by Serbian Association of Dermatovenereologists (SAD)
This work is licensed under the Creative Commons License.